Limitations, agreements, and source contact

A Study of Subcutaneous and Intravenous VELCADE in Patients With Previously Treated Multiple Myeloma · Source last updated 2011-10-10

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

false

restrictive Agreement

false

point Of Contact

email

HVDVELDE@ITS.JNJ.COM

organization

Johnson & Johnson Pharmaceutical Research & Development

title

Helgi Van de Velde, M.D., Ph.D.

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice